Bliss GVS Pharma Financials
NSE: BLISSGVS | BSE: 506197
₹617.20
₹-30.30
(-4.68%)
As on 02-Nov-2026IST
Market cap
₹6,560 Cr
Revenue (TTM)
₹1,074 Cr
P/E Ratio
40.7
P/B Ratio
5.1
Div. Yield
0.2 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
1,074.19
|
927.11
|
809.73
|
770.24
|
751.59
|
747.45
|
|
|
|
|
|
|
Total Income
|
1,121.71
|
1,015.45
|
846.22
|
798.98
|
769.37
|
778.95
|
|
|
|
|
|
|
Total Expenditure
|
837.97
|
777.88
|
683.04
|
619.62
|
634.27
|
629.11
|
|
|
|
|
|
|
EBITDA
|
236.21
|
149.23
|
126.68
|
150.62
|
117.32
|
118.34
|
|
|
|
|
|
|
Depreciation
|
37.46
|
33.48
|
29.42
|
26.38
|
18.67
|
17.33
|
|
|
|
|
|
|
EBIT
|
198.76
|
115.75
|
97.27
|
124.24
|
98.65
|
101.01
|
|
|
|
|
|
|
Interest
|
7.37
|
12.01
|
8.12
|
6.91
|
10.36
|
4.74
|
|
|
|
|
|
|
Other Income
|
47.52
|
88.33
|
36.49
|
28.74
|
17.79
|
31.49
|
|
|
|
|
|
|
Exceptional Items
|
-2.49
|
-2.49
|
--
|
-29.20
|
--
|
-73.59
|
|
|
|
|
|
|
Profit before Tax
|
236.42
|
189.59
|
125.64
|
116.87
|
106.07
|
54.17
|
|
|
|
|
|
|
Provision for Tax
|
69.93
|
54.86
|
35.38
|
35.29
|
29.34
|
31.04
|
|
|
|
|
|
|
Profit after Tax
|
166.49
|
134.73
|
90.26
|
81.58
|
76.73
|
23.13
|
|
|
|
|
|
|
Minority Interest
|
-5.30
|
-5.60
|
-5.96
|
-6.12
|
-5.88
|
-8.09
|
|
|
|
|
|
|
Share of Associate
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
161.19
|
129.13
|
84.30
|
75.45
|
70.86
|
15.04
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
1,290.35
|
1,192.90
|
1,050.38
|
967.19
|
883.90
|
818.70
|
|
|
|
|
|
|
Minority Interest
|
-5.30
|
38.86
|
41.47
|
35.79
|
33.53
|
27.76
|
|
|
|
|
|
|
Non-Current Liabilities
|
21.09
|
8.81
|
37.28
|
51.20
|
42.84
|
29.20
|
|
|
|
|
|
|
Current Liabilities
|
229.83
|
235.54
|
172.16
|
157.41
|
193.26
|
233.09
|
|
|
|
|
|
|
Total Liabilities
|
1,582.31
|
1,492.41
|
1,301.29
|
1,211.59
|
1,156.85
|
1,108.75
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
490.50
|
529.78
|
477.46
|
400.72
|
456.15
|
331.89
|
|
|
|
|
|
|
Current Assets
|
998.96
|
946.34
|
816.66
|
810.87
|
697.37
|
776.86
|
|
|
|
|
|
|
Total Assets
|
1,582.31
|
1,492.41
|
1,301.29
|
1,211.59
|
1,156.85
|
1,108.75
|
|
|
|
|
|
|
Total Debt*
|
--
|
2.93
|
70.97
|
87.81
|
98.07
|
104.96
|
|
|
|
|
|
|
Net Current Assets
|
769.12
|
710.79
|
644.49
|
653.47
|
504.11
|
543.77
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
10.71
|
4.65
|
56.89
|
11.59
|
22.70
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
138.72
|
105.91
|
102.82
|
34.31
|
135.48
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
-38.28
|
-75.59
|
-83.19
|
-7.75
|
-92.98
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
-89.21
|
-30.20
|
-20.89
|
-24.94
|
-23.73
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
11.23
|
0.13
|
-1.27
|
1.62
|
18.78
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
15.33
|
12.21
|
8.00
|
7.21
|
6.80
|
1.45
|
|
|
|
|
|
|
Cash EPS (₹)
|
15.15
|
15.90
|
11.36
|
10.31
|
9.16
|
3.90
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
121.31
|
111.66
|
99.09
|
91.65
|
84.01
|
78.01
|
|
|
|
|
|
|
Dividend per Share (₹)
|
0.24
|
1.50
|
0.50
|
0.50
|
0.50
|
0.50
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
13.11
|
10.05
|
9.82
|
3.29
|
13.07
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
0.66
|
-0.77
|
3.16
|
-8.02
|
3.84
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
17.40
|
12.29
|
12.15
|
12.22
|
6.37
|
|
|
|
|
|
|
ROE (%)
|
13.10
|
12.11
|
9.01
|
8.89
|
9.11
|
2.88
|
|
|
|
|
|
|
ROA (%)
|
11.16
|
9.70
|
7.18
|
6.90
|
6.78
|
2.12
|
|
|
|
|
|
|
EBIT Margin (%)
|
18.50
|
12.49
|
12.01
|
16.13
|
13.13
|
13.51
|
|
|
|
|
|
|
Net Margin (%)
|
14.84
|
13.27
|
10.67
|
10.21
|
9.97
|
2.97
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
17.37
|
14.20
|
14.02
|
12.69
|
5.41
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
24.87
|
14.50
|
5.13
|
2.48
|
0.55
|
29.50
|
|
|
|
|
|
|
EBIT Growth (%)
|
91.79
|
19.00
|
-21.71
|
25.94
|
-2.34
|
12.97
|
|
|
|
|
|
|
Net Profit Growth (%)
|
48.32
|
49.27
|
10.64
|
6.31
|
231.80
|
-68.74
|
|
|
|
|
|
|
EPS Growth (%)
|
46.26
|
52.57
|
11.00
|
5.94
|
368.97
|
-78.15
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
13.14
|
8.82
|
9.65
|
8.19
|
1.30
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
40.70
|
17.66
|
14.69
|
15.63
|
10.47
|
53.04
|
|
|
|
|
|
|
Price / Book Value
|
5.08
|
1.93
|
1.19
|
1.23
|
0.85
|
0.99
|
|
|
|
|
|
|
Dividend Yield (%)
|
0.24
|
0.70
|
0.43
|
0.44
|
0.70
|
0.65
|
|
|
|
|
|
|
EV/EBITDA
|
22.59
|
8.91
|
6.72
|
5.86
|
5.46
|
4.84
|
|
|
|
|
|
|
Close Price (₹)
|
694.45
|
215.59
|
117.78
|
112.85
|
71.15
|
77.10
|
|
|
|
|
|
|
High Price (₹)
|
744.75
|
244.05
|
185.50
|
149.60
|
91.35
|
133.00
|
|
|
|
|
|
|
Low Price (₹)
|
118.00
|
105.05
|
92.15
|
69.15
|
67.30
|
66.10
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
6,560.17
|
2,280.33
|
1,238.64
|
1,179.32
|
742.12
|
797.80
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
0.00
|
0.07
|
0.09
|
0.11
|
0.13
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
0.00
|
0.02
|
0.03
|
0.05
|
0.07
|
|
|
|
|
|
|
Current Ratio
|
4.35
|
4.02
|
4.74
|
5.15
|
3.61
|
3.33
|
|
|
|
|
|
|
Quick Ratio
|
3.53
|
3.38
|
4.01
|
4.40
|
3.08
|
2.80
|
|
|
|
|
|
|
Interest Coverage
|
33.08
|
16.79
|
16.47
|
17.91
|
11.23
|
12.42
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
52.78
|
55.79
|
54.19
|
52.50
|
51.25
|
52.55
|
|
|
|
|
|
|
Asset Turnover
|
0.72
|
0.70
|
0.67
|
0.65
|
0.66
|
0.68
|
|
|
|
|
|
|
Receivable days
|
--
|
180.13
|
182.64
|
187.07
|
188.89
|
209.14
|
|
|
|
|
|
|
Inventory Days
|
--
|
52.09
|
52.89
|
52.48
|
55.12
|
54.42
|
|
|
|
|
|
|
Payable days
|
--
|
75.40
|
58.40
|
70.38
|
81.40
|
77.87
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
156.82
|
177.13
|
169.17
|
162.62
|
185.69
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
